Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera
Clinical trial NCT05548062 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05548062
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-02
- Primary completion
- 2027-08-31
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.